TOP TIERMARKET NEWSWIRE
News & sentiment

Pelthos Therapeutics (PTHS) — News & AI sentiment

Pelthos Therapeutics (PTHS) news roundup. 1 story in the past week, 4 over 30 days. Average 30-day sentiment is 45.3/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $45K — net selling of $45K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 34/100
30d stories
4
avg sentiment 45.3/100
Insider net (90d)
$45K
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

PTHS news in the last 24 hours, 7 days, 30 days and 90 days

How much PTHS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowPTHS storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days134/100PTHS headlines →
Last 30 days445.3/100PTHS headlines →
Last 90 days1550.5/100PTHS headlines →

Latest stories on PTHS

2d ago
Oct 12
Oct 6
Oct 1
Pelthos (PTHS) Q2 2026 Earnings Call Transcript
The Motley Fool67 · bullishearnings
Aug 20
Aug 17
Aug 16
Aug 13
Aug 13
Aug 13
Aug 13
Aug 13
Aug 13
Aug 13
Aug 3
Jul 27
Jul 24
Jul 24
Jun 30
May 28
May 28
Open PTHS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →